Citation Tools

Download PDFPDF

Original research
PRMT5 deficiency in myeloid cells reprograms macrophages to enhance antitumor immunity and synergizes with anti-PD-L1 therapy

Download to a citation manager

Cite this article as:
Chen S, Chen Z, Zhou B, et al
PRMT5 deficiency in myeloid cells reprograms macrophages to enhance antitumor immunity and synergizes with anti-PD-L1 therapy